 Trevor Nydam
Concepts (339)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 42 | 2025 | 871 | 8.210 |
Why?
| | Kidney Transplantation | 15 | 2025 | 709 | 2.600 |
Why?
| | Obesity, Morbid | 7 | 2025 | 264 | 2.600 |
Why?
| | Tissue and Organ Procurement | 9 | 2025 | 321 | 2.580 |
Why?
| | Gastric Bypass | 4 | 2023 | 119 | 2.460 |
Why?
| | Thrombelastography | 14 | 2025 | 154 | 2.390 |
Why?
| | Living Donors | 8 | 2022 | 296 | 1.920 |
Why?
| | Tissue Plasminogen Activator | 7 | 2023 | 225 | 1.900 |
Why?
| | Tissue Donors | 11 | 2025 | 425 | 1.840 |
Why?
| | Blood Coagulation Disorders | 5 | 2025 | 173 | 1.770 |
Why?
| | Organ Preservation | 5 | 2025 | 102 | 1.650 |
Why?
| | Death | 4 | 2023 | 119 | 1.560 |
Why?
| | Fibrinolysis | 6 | 2025 | 147 | 1.410 |
Why?
| | Donor Selection | 6 | 2025 | 77 | 1.220 |
Why?
| | Bariatric Surgery | 3 | 2025 | 217 | 1.210 |
Why?
| | Perfusion | 3 | 2025 | 214 | 1.120 |
Why?
| | Gastrectomy | 7 | 2025 | 126 | 1.110 |
Why?
| | Graft Survival | 12 | 2025 | 536 | 1.100 |
Why?
| | Carcinoma, Hepatocellular | 8 | 2023 | 362 | 1.030 |
Why?
| | Kidney Failure, Chronic | 5 | 2025 | 570 | 0.960 |
Why?
| | Cold Ischemia | 4 | 2021 | 30 | 0.960 |
Why?
| | Blood Transfusion | 5 | 2025 | 326 | 0.910 |
Why?
| | Liver Neoplasms | 8 | 2023 | 786 | 0.840 |
Why?
| | Kidney | 8 | 2022 | 1475 | 0.830 |
Why?
| | Delayed Graft Function | 3 | 2022 | 33 | 0.800 |
Why?
| | Primary Graft Dysfunction | 1 | 2023 | 32 | 0.780 |
Why?
| | Hepatitis C | 3 | 2022 | 271 | 0.770 |
Why?
| | Resuscitation | 2 | 2024 | 251 | 0.760 |
Why?
| | End Stage Liver Disease | 6 | 2023 | 82 | 0.740 |
Why?
| | Organ Transplantation | 3 | 2025 | 251 | 0.700 |
Why?
| | Reperfusion | 1 | 2020 | 40 | 0.670 |
Why?
| | Hemostatic Techniques | 1 | 2020 | 46 | 0.650 |
Why?
| | Blood Component Transfusion | 1 | 2020 | 84 | 0.650 |
Why?
| | Hepatitis C, Chronic | 1 | 2022 | 164 | 0.640 |
Why?
| | Humans | 78 | 2025 | 137782 | 0.630 |
Why?
| | Decision Support Techniques | 7 | 2025 | 421 | 0.620 |
Why?
| | Amino Acid Chloromethyl Ketones | 1 | 2018 | 25 | 0.590 |
Why?
| | Graft Rejection | 2 | 2020 | 624 | 0.590 |
Why?
| | Heart Failure | 2 | 2023 | 2237 | 0.590 |
Why?
| | Organ Preservation Solutions | 1 | 2018 | 45 | 0.580 |
Why?
| | Apoptosis | 5 | 2021 | 2553 | 0.580 |
Why?
| | Caspase Inhibitors | 1 | 2018 | 81 | 0.580 |
Why?
| | Postoperative Complications | 4 | 2024 | 2659 | 0.570 |
Why?
| | Blood Coagulation | 6 | 2023 | 257 | 0.560 |
Why?
| | Pneumoperitoneum | 1 | 2017 | 12 | 0.560 |
Why?
| | Thrombophilia | 1 | 2018 | 83 | 0.560 |
Why?
| | Klebsiella Infections | 1 | 2017 | 26 | 0.560 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2018 | 77 | 0.550 |
Why?
| | Cholecystitis | 1 | 2017 | 24 | 0.550 |
Why?
| | Cholecystectomy | 1 | 2017 | 62 | 0.540 |
Why?
| | Quinolines | 1 | 2018 | 178 | 0.540 |
Why?
| | Heart Transplantation | 1 | 2023 | 755 | 0.530 |
Why?
| | Wounds and Injuries | 5 | 2025 | 760 | 0.530 |
Why?
| | Liver | 7 | 2022 | 1943 | 0.530 |
Why?
| | Neoplasm Recurrence, Local | 7 | 2024 | 1080 | 0.520 |
Why?
| | Middle Aged | 32 | 2025 | 33554 | 0.510 |
Why?
| | Retrospective Studies | 22 | 2024 | 15682 | 0.490 |
Why?
| | Renal Nutcracker Syndrome | 2 | 2025 | 9 | 0.460 |
Why?
| | Parents | 2 | 2020 | 1350 | 0.450 |
Why?
| | Brain Death | 4 | 2025 | 46 | 0.430 |
Why?
| | Non-alcoholic Fatty Liver Disease | 3 | 2024 | 279 | 0.420 |
Why?
| | Male | 41 | 2025 | 67906 | 0.380 |
Why?
| | Pancreatic Neoplasms | 4 | 2024 | 938 | 0.380 |
Why?
| | Acute Kidney Injury | 4 | 2021 | 815 | 0.370 |
Why?
| | Registries | 1 | 2020 | 2041 | 0.370 |
Why?
| | Creatinine | 4 | 2023 | 499 | 0.370 |
Why?
| | Health Services Accessibility | 3 | 2025 | 991 | 0.370 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2014 | 1242 | 0.360 |
Why?
| | Saline Solution, Hypertonic | 3 | 2014 | 41 | 0.360 |
Why?
| | Obesity | 6 | 2025 | 2993 | 0.350 |
Why?
| | Treatment Outcome | 16 | 2025 | 10837 | 0.340 |
Why?
| | Waiting Lists | 6 | 2025 | 266 | 0.340 |
Why?
| | Female | 34 | 2025 | 73465 | 0.330 |
Why?
| | Multiple Organ Failure | 1 | 2011 | 128 | 0.330 |
Why?
| | Predictive Value of Tests | 7 | 2025 | 2041 | 0.320 |
Why?
| | NF-kappa B | 4 | 2014 | 691 | 0.320 |
Why?
| | Adenocarcinoma | 3 | 2024 | 940 | 0.310 |
Why?
| | Ablation Techniques | 2 | 2020 | 36 | 0.310 |
Why?
| | Transplant Recipients | 2 | 2022 | 184 | 0.300 |
Why?
| | Warm Ischemia | 2 | 2020 | 12 | 0.300 |
Why?
| | Thrombocytopenia | 1 | 2011 | 200 | 0.300 |
Why?
| | Renal Veins | 2 | 2025 | 19 | 0.300 |
Why?
| | Adult | 22 | 2025 | 38023 | 0.290 |
Why?
| | Thrombosis | 3 | 2022 | 371 | 0.290 |
Why?
| | Time Factors | 12 | 2025 | 6834 | 0.290 |
Why?
| | United States | 14 | 2025 | 14870 | 0.280 |
Why?
| | Transplantation, Autologous | 2 | 2025 | 241 | 0.260 |
Why?
| | Survival Rate | 5 | 2024 | 1973 | 0.250 |
Why?
| | Markov Chains | 5 | 2025 | 126 | 0.250 |
Why?
| | Necrosis | 3 | 2021 | 246 | 0.250 |
Why?
| | Risk Factors | 11 | 2023 | 10407 | 0.240 |
Why?
| | Receptors, Gastrointestinal Hormone | 1 | 2025 | 9 | 0.240 |
Why?
| | Aged | 16 | 2025 | 24001 | 0.230 |
Why?
| | Fibrinolysin | 1 | 2025 | 20 | 0.230 |
Why?
| | Epithelial Cells | 3 | 2014 | 1096 | 0.230 |
Why?
| | Metabolomics | 3 | 2019 | 678 | 0.230 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 373 | 0.230 |
Why?
| | Coronavirus Infections | 2 | 2020 | 364 | 0.230 |
Why?
| | Flank Pain | 1 | 2024 | 10 | 0.230 |
Why?
| | Weight Loss | 4 | 2025 | 788 | 0.220 |
Why?
| | Colonoscopy | 1 | 2007 | 245 | 0.220 |
Why?
| | Prospective Studies | 4 | 2020 | 7623 | 0.220 |
Why?
| | Tumor Burden | 3 | 2020 | 309 | 0.220 |
Why?
| | Tissue and Organ Harvesting | 1 | 2024 | 70 | 0.210 |
Why?
| | Lung | 3 | 2014 | 4060 | 0.210 |
Why?
| | Salvage Therapy | 2 | 2024 | 142 | 0.210 |
Why?
| | Choledochostomy | 1 | 2022 | 11 | 0.200 |
Why?
| | Anastomosis, Roux-en-Y | 1 | 2022 | 28 | 0.200 |
Why?
| | Caspase 1 | 2 | 2021 | 144 | 0.200 |
Why?
| | Plasminogen Activator Inhibitor 1 | 2 | 2022 | 87 | 0.200 |
Why?
| | Risk Assessment | 7 | 2022 | 3461 | 0.200 |
Why?
| | Antiviral Agents | 2 | 2022 | 744 | 0.190 |
Why?
| | Bile Ducts | 1 | 2022 | 71 | 0.190 |
Why?
| | Lymph | 2 | 2016 | 32 | 0.190 |
Why?
| | Allografts | 1 | 2023 | 146 | 0.190 |
Why?
| | Preoperative Period | 2 | 2019 | 129 | 0.180 |
Why?
| | Hemostatics | 1 | 2022 | 52 | 0.180 |
Why?
| | Ventricular Remodeling | 1 | 2023 | 268 | 0.180 |
Why?
| | Stents | 1 | 2025 | 527 | 0.180 |
Why?
| | Surgeons | 1 | 2025 | 297 | 0.170 |
Why?
| | Nephrectomy | 2 | 2020 | 169 | 0.170 |
Why?
| | Reperfusion Injury | 2 | 2021 | 279 | 0.170 |
Why?
| | Intraoperative Period | 1 | 2020 | 59 | 0.170 |
Why?
| | Cell Line | 3 | 2018 | 2847 | 0.170 |
Why?
| | Computer Systems | 1 | 2020 | 45 | 0.170 |
Why?
| | Shock, Hemorrhagic | 2 | 2016 | 167 | 0.170 |
Why?
| | Models, Animal | 2 | 2020 | 384 | 0.170 |
Why?
| | Viscosity | 1 | 2020 | 92 | 0.170 |
Why?
| | Pancreatectomy | 2 | 2024 | 253 | 0.170 |
Why?
| | Liver Function Tests | 1 | 2020 | 114 | 0.160 |
Why?
| | Feasibility Studies | 1 | 2024 | 963 | 0.160 |
Why?
| | Short Bowel Syndrome | 1 | 2020 | 26 | 0.160 |
Why?
| | Blood Coagulation Tests | 1 | 2020 | 67 | 0.160 |
Why?
| | Caspase 3 | 2 | 2018 | 246 | 0.160 |
Why?
| | Hepacivirus | 1 | 2022 | 261 | 0.160 |
Why?
| | Toll-Like Receptor 4 | 1 | 2021 | 273 | 0.150 |
Why?
| | Thromboembolism | 1 | 2020 | 119 | 0.150 |
Why?
| | Digestive System Surgical Procedures | 1 | 2020 | 106 | 0.150 |
Why?
| | Surgical Wound Infection | 1 | 2022 | 307 | 0.150 |
Why?
| | Liver Diseases | 1 | 2022 | 315 | 0.150 |
Why?
| | Transplantation, Homologous | 1 | 2020 | 416 | 0.150 |
Why?
| | Follow-Up Studies | 4 | 2020 | 5136 | 0.150 |
Why?
| | Mice, Inbred C57BL | 5 | 2021 | 5764 | 0.140 |
Why?
| | Critical Care | 1 | 2023 | 610 | 0.140 |
Why?
| | Klebsiella pneumoniae | 1 | 2017 | 47 | 0.140 |
Why?
| | Case-Control Studies | 3 | 2023 | 3569 | 0.140 |
Why?
| | Platelet Count | 2 | 2022 | 86 | 0.140 |
Why?
| | Plasma | 2 | 2016 | 212 | 0.130 |
Why?
| | Drug Overdose | 1 | 2021 | 347 | 0.130 |
Why?
| | Goals | 1 | 2018 | 170 | 0.130 |
Why?
| | Young Adult | 7 | 2024 | 13240 | 0.130 |
Why?
| | Hepatectomy | 1 | 2018 | 251 | 0.130 |
Why?
| | Arteriovenous Anastomosis | 1 | 2015 | 13 | 0.120 |
Why?
| | Aortic Valve Insufficiency | 1 | 2015 | 47 | 0.120 |
Why?
| | Vascular Surgical Procedures | 2 | 2015 | 303 | 0.120 |
Why?
| | Airway Extubation | 1 | 2016 | 57 | 0.120 |
Why?
| | Aorta, Abdominal | 1 | 2015 | 46 | 0.120 |
Why?
| | Renal Artery | 1 | 2015 | 37 | 0.120 |
Why?
| | ABO Blood-Group System | 1 | 2015 | 51 | 0.110 |
Why?
| | Isoantibodies | 1 | 2015 | 60 | 0.110 |
Why?
| | Rewarming | 1 | 2014 | 20 | 0.110 |
Why?
| | Microsurgery | 1 | 2015 | 75 | 0.110 |
Why?
| | Early Detection of Cancer | 1 | 2019 | 448 | 0.110 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2016 | 157 | 0.110 |
Why?
| | Phosphorylation | 4 | 2014 | 1759 | 0.110 |
Why?
| | Kidney Tubules | 1 | 2014 | 117 | 0.110 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2015 | 130 | 0.110 |
Why?
| | Opioid-Related Disorders | 1 | 2021 | 515 | 0.110 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2018 | 351 | 0.100 |
Why?
| | Incidence | 1 | 2020 | 2804 | 0.100 |
Why?
| | Erythrocyte Transfusion | 2 | 2016 | 194 | 0.100 |
Why?
| | Cholestasis | 1 | 2016 | 235 | 0.100 |
Why?
| | Age Factors | 4 | 2021 | 3305 | 0.100 |
Why?
| | Osmolar Concentration | 1 | 2013 | 171 | 0.100 |
Why?
| | Aortic Valve Stenosis | 1 | 2015 | 229 | 0.100 |
Why?
| | Metabolome | 1 | 2016 | 350 | 0.100 |
Why?
| | Interleukin-1beta | 1 | 2014 | 372 | 0.100 |
Why?
| | Biomarkers | 3 | 2019 | 4154 | 0.100 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1276 | 0.100 |
Why?
| | Recovery of Function | 1 | 2016 | 653 | 0.090 |
Why?
| | Microvessels | 1 | 2013 | 88 | 0.090 |
Why?
| | Autophagy | 1 | 2014 | 284 | 0.090 |
Why?
| | Sirolimus | 1 | 2013 | 276 | 0.090 |
Why?
| | Patient Selection | 1 | 2015 | 696 | 0.090 |
Why?
| | Models, Biological | 1 | 2019 | 1783 | 0.090 |
Why?
| | Disease Models, Animal | 2 | 2020 | 4295 | 0.090 |
Why?
| | Animals | 9 | 2021 | 36951 | 0.090 |
Why?
| | Liver Cirrhosis | 1 | 2013 | 316 | 0.090 |
Why?
| | Neoplasms | 1 | 2025 | 2673 | 0.080 |
Why?
| | Shock | 2 | 2024 | 98 | 0.080 |
Why?
| | Hypoxia | 1 | 2016 | 1112 | 0.070 |
Why?
| | Injury Severity Score | 1 | 2011 | 522 | 0.070 |
Why?
| | Postoperative Period | 2 | 2020 | 342 | 0.070 |
Why?
| | Immunosuppressive Agents | 1 | 2013 | 894 | 0.070 |
Why?
| | Transcription, Genetic | 1 | 2014 | 1457 | 0.070 |
Why?
| | Kidney Function Tests | 2 | 2020 | 160 | 0.070 |
Why?
| | Odds Ratio | 1 | 2011 | 1070 | 0.070 |
Why?
| | Renal Dialysis | 2 | 2023 | 435 | 0.070 |
Why?
| | Mice | 6 | 2021 | 17794 | 0.070 |
Why?
| | Neoadjuvant Therapy | 2 | 2020 | 404 | 0.070 |
Why?
| | Colonoscopes | 1 | 2007 | 5 | 0.070 |
Why?
| | Microscopy, Fluorescence | 1 | 2009 | 402 | 0.070 |
Why?
| | Protein Transport | 1 | 2009 | 445 | 0.070 |
Why?
| | Barium Sulfate | 1 | 2007 | 15 | 0.070 |
Why?
| | I-kappa B Kinase | 1 | 2007 | 55 | 0.070 |
Why?
| | Cecum | 1 | 2007 | 33 | 0.070 |
Why?
| | Mesentery | 1 | 2007 | 48 | 0.070 |
Why?
| | Betacoronavirus | 2 | 2020 | 270 | 0.070 |
Why?
| | Paraneoplastic Syndromes | 1 | 2007 | 12 | 0.070 |
Why?
| | Enema | 1 | 2007 | 47 | 0.070 |
Why?
| | Cause of Death | 2 | 2021 | 436 | 0.060 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2007 | 67 | 0.060 |
Why?
| | Gastrointestinal Stromal Tumors | 1 | 2007 | 38 | 0.060 |
Why?
| | Blotting, Western | 1 | 2009 | 1227 | 0.060 |
Why?
| | Leukocytes, Mononuclear | 1 | 2009 | 558 | 0.060 |
Why?
| | Inflammation Mediators | 1 | 2009 | 513 | 0.060 |
Why?
| | Quality of Life | 1 | 2018 | 2894 | 0.060 |
Why?
| | Recurrence | 2 | 2023 | 1061 | 0.060 |
Why?
| | Cell Survival | 1 | 2009 | 1120 | 0.060 |
Why?
| | Logistic Models | 1 | 2011 | 2075 | 0.060 |
Why?
| | Survival Analysis | 2 | 2020 | 1325 | 0.060 |
Why?
| | Flow Cytometry | 1 | 2009 | 1178 | 0.060 |
Why?
| | Child | 6 | 2022 | 21989 | 0.060 |
Why?
| | Mass Spectrometry | 2 | 2019 | 739 | 0.060 |
Why?
| | Adolescent | 5 | 2024 | 21574 | 0.050 |
Why?
| | Ampulla of Vater | 1 | 2024 | 42 | 0.050 |
Why?
| | Trauma Centers | 1 | 2006 | 421 | 0.050 |
Why?
| | Databases, Factual | 2 | 2021 | 1357 | 0.050 |
Why?
| | Erythrocytes | 1 | 2009 | 700 | 0.050 |
Why?
| | Inflammation | 1 | 2014 | 2838 | 0.050 |
Why?
| | Aged, 80 and over | 4 | 2020 | 7637 | 0.050 |
Why?
| | Costs and Cost Analysis | 1 | 2024 | 213 | 0.050 |
Why?
| | Proportional Hazards Models | 2 | 2017 | 1266 | 0.050 |
Why?
| | Perioperative Period | 1 | 2022 | 56 | 0.050 |
Why?
| | Robotic Surgical Procedures | 1 | 2024 | 130 | 0.050 |
Why?
| | ROC Curve | 1 | 2024 | 554 | 0.050 |
Why?
| | Pain Measurement | 1 | 2024 | 524 | 0.050 |
Why?
| | Propensity Score | 1 | 2023 | 294 | 0.050 |
Why?
| | Platelet Transfusion | 1 | 2022 | 67 | 0.050 |
Why?
| | Hemostasis | 1 | 2022 | 82 | 0.050 |
Why?
| | Patients | 1 | 2023 | 175 | 0.050 |
Why?
| | Pandemics | 2 | 2020 | 1639 | 0.040 |
Why?
| | Neoplasm Staging | 2 | 2020 | 1389 | 0.040 |
Why?
| | Cytokines | 1 | 2009 | 2085 | 0.040 |
Why?
| | Child Abuse | 1 | 2006 | 537 | 0.040 |
Why?
| | Severity of Illness Index | 2 | 2020 | 2836 | 0.040 |
Why?
| | Fibrin Clot Lysis Time | 1 | 2020 | 9 | 0.040 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2020 | 87 | 0.040 |
Why?
| | Partial Thromboplastin Time | 1 | 2020 | 57 | 0.040 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2020 | 220 | 0.040 |
Why?
| | Tomography, X-Ray Computed | 2 | 2007 | 2697 | 0.040 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2020 | 82 | 0.040 |
Why?
| | Blood Viscosity | 1 | 2019 | 17 | 0.040 |
Why?
| | Databases as Topic | 1 | 1999 | 67 | 0.040 |
Why?
| | Colorectal Neoplasms | 1 | 2007 | 807 | 0.040 |
Why?
| | Infant, Newborn | 2 | 2021 | 6084 | 0.040 |
Why?
| | alpha-Fetoproteins | 1 | 2019 | 46 | 0.040 |
Why?
| | Disease-Free Survival | 1 | 2020 | 686 | 0.040 |
Why?
| | Blood Platelets | 1 | 2022 | 408 | 0.040 |
Why?
| | Long-Term Care | 1 | 1999 | 107 | 0.040 |
Why?
| | Ischemia | 1 | 2020 | 409 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2020 | 326 | 0.030 |
Why?
| | Lymphatic Metastasis | 1 | 2018 | 352 | 0.030 |
Why?
| | Body Mass Index | 1 | 2025 | 2390 | 0.030 |
Why?
| | Discriminant Analysis | 1 | 2016 | 37 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2024 | 1002 | 0.030 |
Why?
| | Least-Squares Analysis | 1 | 2016 | 79 | 0.030 |
Why?
| | Sepsis | 1 | 2022 | 617 | 0.030 |
Why?
| | Preoperative Care | 1 | 2018 | 362 | 0.030 |
Why?
| | Mutation | 1 | 2007 | 3959 | 0.030 |
Why?
| | Renal Artery Obstruction | 1 | 2015 | 30 | 0.030 |
Why?
| | Transplants | 1 | 2015 | 36 | 0.030 |
Why?
| | Renal Circulation | 1 | 2015 | 65 | 0.030 |
Why?
| | Likelihood Functions | 1 | 2015 | 144 | 0.030 |
Why?
| | Disease Management | 1 | 2019 | 629 | 0.030 |
Why?
| | Endothelial Cells | 2 | 2013 | 785 | 0.030 |
Why?
| | Signal Transduction | 2 | 2021 | 5081 | 0.030 |
Why?
| | United States Department of Veterans Affairs | 1 | 1999 | 679 | 0.030 |
Why?
| | Anastomosis, Surgical | 1 | 2015 | 153 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2016 | 501 | 0.030 |
Why?
| | Femoral Artery | 1 | 2015 | 179 | 0.030 |
Why?
| | Transcription Factor RelA | 1 | 2014 | 87 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1236 | 0.030 |
Why?
| | Macrolides | 1 | 2014 | 65 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2020 | 832 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2021 | 3018 | 0.030 |
Why?
| | Critical Illness | 1 | 2020 | 815 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2016 | 597 | 0.030 |
Why?
| | Hemoglobins | 1 | 2016 | 353 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2014 | 4193 | 0.030 |
Why?
| | Reoperation | 1 | 2016 | 573 | 0.030 |
Why?
| | Hepatocytes | 1 | 2014 | 220 | 0.030 |
Why?
| | Motivation | 1 | 2018 | 570 | 0.030 |
Why?
| | Leukocytes | 1 | 2014 | 311 | 0.020 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2013 | 139 | 0.020 |
Why?
| | Disease Progression | 1 | 2020 | 2760 | 0.020 |
Why?
| | Swine | 1 | 2014 | 775 | 0.020 |
Why?
| | Interleukin-8 | 1 | 2013 | 268 | 0.020 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 283 | 0.020 |
Why?
| | Infant | 2 | 2021 | 9482 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2015 | 1509 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2013 | 466 | 0.020 |
Why?
| | Cell Communication | 1 | 2013 | 315 | 0.020 |
Why?
| | Child, Preschool | 2 | 2021 | 11105 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 4039 | 0.020 |
Why?
| | Hemodynamics | 1 | 2015 | 1113 | 0.020 |
Why?
| | Acute Lung Injury | 1 | 2013 | 287 | 0.020 |
Why?
| | Cell Transplantation | 1 | 2009 | 37 | 0.020 |
Why?
| | Lymphocyte Depletion | 1 | 2009 | 135 | 0.020 |
Why?
| | Paracrine Communication | 1 | 2009 | 65 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2016 | 1586 | 0.020 |
Why?
| | Veterans | 1 | 1999 | 1479 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2015 | 3290 | 0.020 |
Why?
| | Neutrophils | 1 | 2013 | 1238 | 0.020 |
Why?
| | Laparotomy | 1 | 2007 | 109 | 0.020 |
Why?
| | Up-Regulation | 1 | 2009 | 843 | 0.020 |
Why?
| | Intestine, Small | 1 | 2007 | 156 | 0.020 |
Why?
| | Exons | 1 | 2007 | 355 | 0.010 |
Why?
| | Lipopolysaccharides | 1 | 2009 | 886 | 0.010 |
Why?
| | Blood Preservation | 1 | 2009 | 285 | 0.010 |
Why?
| | Lymphocyte Activation | 1 | 2009 | 1142 | 0.010 |
Why?
| | Cell Nucleus | 1 | 2007 | 620 | 0.010 |
Why?
| | Hypoglycemia | 1 | 2007 | 445 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2007 | 2487 | 0.010 |
Why?
| | Glucose | 1 | 2007 | 1020 | 0.010 |
Why?
| | Manuals as Topic | 1 | 1999 | 14 | 0.010 |
Why?
| | Rats | 1 | 2007 | 5648 | 0.010 |
Why?
| | Demography | 1 | 1999 | 291 | 0.010 |
Why?
| | Health Resources | 1 | 1999 | 121 | 0.010 |
Why?
| | Health Services Needs and Demand | 1 | 1999 | 273 | 0.010 |
Why?
| | Patient Admission | 1 | 1999 | 197 | 0.010 |
Why?
| | Nursing Homes | 1 | 1999 | 181 | 0.010 |
Why?
| | Colorado | 1 | 2006 | 4576 | 0.010 |
Why?
| | Women's Health | 1 | 1999 | 372 | 0.010 |
Why?
| | Data Collection | 1 | 1999 | 673 | 0.010 |
Why?
| | Ambulatory Care | 1 | 1999 | 546 | 0.010 |
Why?
| | Internet | 1 | 1999 | 655 | 0.010 |
Why?
| | Sex Factors | 1 | 1999 | 2077 | 0.010 |
Why?
| | Hospitalization | 1 | 1999 | 2200 | 0.000 |
Why?
|
|
Nydam's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|